These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25936561)

  • 1. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
    Want MY; Islamuddin M; Chouhan G; Ozbak HA; Hemeg HA; Dasgupta AK; Chattopadhyay AP; Afrin F
    Colloids Surf B Biointerfaces; 2015 Jun; 130():215-21. PubMed ID: 25936561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis.
    Want MY; Islammudin M; Chouhan G; Ozbak HA; Hemeg HA; Chattopadhyay AP; Afrin F
    Int J Nanomedicine; 2017; 12():2189-2204. PubMed ID: 28356736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of artemisinin in experimental visceral leishmaniasis.
    Sen R; Ganguly S; Saha P; Chatterjee M
    Int J Antimicrob Agents; 2010 Jul; 36(1):43-9. PubMed ID: 20403680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies.
    Want MY; Islamuddin M; Chouhan G; Dasgupta AK; Chattopadhyay AP; Afrin F
    J Colloid Interface Sci; 2014 Oct; 432():258-69. PubMed ID: 25086720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis.
    Akbari M; Heli H; Oryan A; Hatam G
    Pathog Glob Health; 2024 Feb; 118(1):40-46. PubMed ID: 37183476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo.
    Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK
    Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.
    Afrin F; Chouhan G; Islamuddin M; Want MY; Ozbak HA; Hemeg HA
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007227. PubMed ID: 31071090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.
    Islamuddin M; Chouhan G; Farooque A; Dwarakanath BS; Sahal D; Afrin F
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3321. PubMed ID: 25568967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.
    Ghosh S; Kar N; Bera T
    Int J Biol Macromol; 2016 Dec; 93(Pt A):961-970. PubMed ID: 27645930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice.
    Agallou M; Athanasiou E; Kammona O; Tastsoglou S; Hatzigeorgiou AG; Kiparissides C; Karagouni E
    Front Immunol; 2019; 10():2749. PubMed ID: 31849951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Parasitol Res; 2013 Jun; 112(6):2269-80. PubMed ID: 23519426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis.
    Kaur T; Makkar P; Randhawa K; Kaur S
    Parasitol Res; 2013 Jan; 112(1):91-100. PubMed ID: 22961311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.
    Joshi J; Malla N; Kaur S
    Parasitol Int; 2014 Aug; 63(4):612-20. PubMed ID: 24747611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
    Joshi J; Kaur S
    Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.